Effect of dialysis membrane biocompatibility on polymorphonuclear granulocyte activity in dialysis patients

被引:20
作者
Banche, Giuliana
Allizond, Valeria
Giacchino, Franca
Mandras, Narcisa
Roana, Janira
Bonello, Franco
Belardi, Paola
Tullio, Vivian
Merlino, Chiara
Carlone, Nicola
Cuffini, Anna Maria
机构
[1] Univ Turin, Dept Publ Hlth & Microbiol, Microbiol Sect, I-10126 Turin, Italy
[2] Civil Hosp, Dept Internal Med, Nephrol & Dialysis Unit, Ivrea, Italy
关键词
chronic renal insufficiency; dialysis membrane; human polymorphonuclear cells; intracellular killing; Klebsiella pneumoniae; phagocytosis; LONG-TERM USE; OXIDATIVE STRESS; CO-AMOXICLAV; HEMODIALYSIS; PHAGOCYTOSIS; CELLULOSE; IMPACT; UREMIA;
D O I
10.1093/ndt/gfl415
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Background. Among patients with defects of the phagocytic component of the immune system, chronic haemodialysis patients are highly susceptible to microbial infections characterized by high morbidity/mortality, related to an impairment of the phagocytic response. Therefore the potential influence of dialysis membrane biocompatibility on the activity of polymorphonuclear (PMN) granulocytes from dialysis patients was investigated in this study. Methods. Nineteen patients in haemodialysis were included in the protocol and divided into two groups: a control group (7 patients) and a study group (12 patients). The study group patients were treated for subsequent periods of 1 month with different dialysis membranes: low flux excebrane E membrane (CL-E), low flux polysulfone (PS). The control group patients were treated with a low flux modified cellulose membrane (SMC) for the entire observation period. The aetiology of end-stage renal disease included glomerulonephritis, nephroangiosclerosis and interstitial nephropathy. Following each period of treatment, clinical and haematological parameters were evaluated; phagocytosis and microbicidal activity of PMNs from uraemic patients against Klebsiella pneumoniae, the pathogen which can pose severe problems in immune depressed patients, were investigated in parallel. Results. The data evidence that both clinical and haematological parameters remained unchanged during the study period and no differences were found among treatments. On the contrary, the PMN activity varied according to the type of the membrane. In fact, the use of both PS and CL-E, in contrast to SMC, resulted in a PMN functionality similar to that observed in healthy subjects. Conclusions. These results provide evidence that the depressed PMN activities in dialysis patients may be influenced by membrane biocompatibility in such a way to be totally restored.
引用
收藏
页码:3532 / 3538
页数:7
相关论文
共 29 条
[1]
Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO study [J].
Allon, M ;
Depner, TA ;
Radeva, M ;
Bailey, J ;
Beddhu, S ;
Butterly, D ;
Coyne, DW ;
Gassman, JJ ;
Kaufman, AM ;
Kaysen, GA ;
Lewis, JA ;
Schwab, SJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07) :1863-1870
[2]
The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing [J].
Anding, K ;
Gross, P ;
Rost, JM ;
Allgaier, D ;
Jacobs, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (10) :2067-2073
[3]
Synthetically modified cellulose (SMC) - A cellulosic hemodialysis membrane with minimized complement activation [J].
Bowry, SK ;
Rintelen, TH .
ASAIO JOURNAL, 1998, 44 (05) :M579-M583
[4]
Cohen G, 1998, J AM SOC NEPHROL, V9, P451
[5]
Impact of co-amoxiclav on polymorphonuclear granulocytes from chronic hemodialysis patients [J].
Cuffini, AM ;
Tullio, V ;
Giacchino, F ;
Mandras, N ;
Scalas, D ;
Belardi, P ;
Merlino, C ;
Carlone, NA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (06) :1253-1259
[6]
Cuffini AM, 2001, TRANSPLANTATION, V71, P575
[7]
DESCAMPSLATSCHA B, 1995, PRESSE MED, V24, P405
[8]
Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis [J].
Gastaldello, K ;
Husson, C ;
Wens, R ;
Vanherweghem, JL ;
Tielemans, C .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (10) :1638-1646
[9]
Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction [J].
Girndt, M ;
Lengler, S ;
Kaul, H ;
Sester, U ;
Sester, M ;
Köhler, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (01) :95-104
[10]
Haag-Weber M, 1995, New Horiz, V3, P669